Acorah Software Products - Accounts Production 19.4.300 false true false true No description of principal activity 25 March 2025 31 March 2026 31 March 2026 16342062 Mrs Amy Luther iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16342062 2025-03-24 16342062 2026-03-31 16342062 2025-03-25 2026-03-31 16342062 frs-core:CurrentFinancialInstruments 2026-03-31 16342062 frs-bus:PrivateLimitedCompanyLtd 2025-03-25 2026-03-31 16342062 frs-bus:FilletedAccounts 2025-03-25 2026-03-31 16342062 frs-bus:Micro-entities 2025-03-25 2026-03-31 16342062 frs-bus:AuditExempt-NoAccountantsReport 2025-03-25 2026-03-31 16342062 frs-bus:Director1 2025-03-25 2026-03-31
Registered number: 16342062
Molecular Medical Services Ltd
Financial Statements
For The Year Ended 31 March 2026
My Accountant Friend
50 St Marys Road
Hemel Hempstead
Herts
HP2 5HL
Balance Sheet
Registered number: 16342062
2026
£
Current assets 76,186
Creditors: Amounts Falling Due Within One Year (34,744 )
NET CURRENT ASSETS 41,442
TOTAL ASSETS LESS CURRENT LIABILITIES 41,442
NET ASSETS 41,442
CAPITAL AND RESERVES 41,442

Notes

1. General Information
Molecular Medical Services Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16342062 . The registered office is Lamorak House Arthurs Court, Sleepers Hill, Winchester, SO22 4NB.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mrs Amy Luther
Director
26/08/2026